Delivery Order SPE2DB20D2002-SPE2DB25FL72W
- Not listed
- AmerisourceBergen Drug Corp was awarded a $1,978.18 delivery order by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles). This firm fixed-price, competitively awarded contract is scheduled for completion by September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child delivery order under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $2,855.75. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. The contract is scheduled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $9,456.85. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract's ultimate completion date is September 12, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count units) with a ceiling value of $2,478.27. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the order from its...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,189.40. This firm fixed-price delivery order, which is not set-aside, represents a competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) valued at $4,498.98. This competitive award (no set-aside used) is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count) with a ceiling value of $1,346.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on April 25, 2025, and performance will occur at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) under a firm fixed-price contract valued at $2,729.30. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. The...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. The contract is valued at $1,541.16 with a firm fixed price structure and an ultimate completion date of August 4, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 tablets, with a ceiling value of $11,400.02. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The delivery order is expected to be completed by September 18, 2025, and will be performed at the vendor's corporate office location in...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL72WDelivery Order
AmerisourceBergen Drug Corp received a delivery order from the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units, with a contract ceiling value of $3,523.73. The award, which is non-competitive and represents a child contract under a larger vehicle, is scheduled for completion by September 4, 2025. This delivery order operates under a firm fixed price structure and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The Methylphenidate delivery represents one of numerous pharmaceutical transactions fulfilling the Defense Health Agency's medical supply needs across multiple therapeutic domains, demonstrating AmerisourceBergen's critical role in the federal pharmaceutical supply chain for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/3/25 |